Mayne's growth strategy is set to deliver
Mayne Pharma remains one of the most sought-after growth stocks on the ASX and a stronger US dollar will help further.
Growth and rates in focus
GDP for the June quarter is released on Wednesday and forecasts indicate growth will slow to around 0.4 per cent from 1.1 per cent in the first quarter.
Oil import costs may become Asia's growing pain
A widening gap between Asia's oil production and demand is creating a growing capital drain for the region.
Finding growth in unloved industrials
Fund manager Artisan's Mike Schneider finds technologies that are on the cusp of new applications or geographies.
US jobs data casts doubt on rate rise
Soft hiring means an imminent rate hike would surprise many, but not Goldman Sachs.
Samarco hires US lawyers for debt talks
Samarco bondholders hired US law firm Hogan Lovells for help with debt-restructuring talks.
Wall St higher on job data
US stocks rose as August payroll data signalled steady jobs growth, tempering bets on a rate lift.
Bill Gross sees September rate hike
Bill Gross says August's jobs data ensure the Federal Reserve will raise interest rates this month.
US economy adds 151,000 jobs in August
US payrolls grew at a slower but solid pace in August while measures of labour slack were flat.
Why the old valuation rules don't work
Low bond yields have been providing an artificial boost to cash flow-based valuations for years.
